The Hip Preservation market is growing quickly but is still not reimbursed

this patient had to get a total joint replacement at the age of 22. And we're seeing too much of this right now, and this is what we're trying to solve. So we know this, we can look at other markers too that this market is growing. I mean, if you look at just the injectable market, $1.3 billion market this year, growing at about 8%. So these patients are reaching into their pocket, willing to pay $1,600 to get a course of 3 injections to, to start to address their problems. And so, so this is a desperate patient population. And so one of the things that we're having, I'd love, love comments on this from you guys, is obviously we have to improve patient care with Renew hip implant and we have to, to lower costs and we have to have it reimbursed. We're gonna have to collect these data, get it into the clinical trial.